RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)

Historical Holders from Q2 2024 to Q3 2025

Symbol
RIGL on Nasdaq
CUSIP
766559702
Type / Class
Equity / Common Stock
Shares outstanding
16.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
15M
Holdings value
$425M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
164
Number of buys
102
Number of sells
-54
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.48% +27.7% $25.8M $6.2M 1.52M +31.6% Armistice Capital, LLC Mar 31, 2025
BlackRock, Inc. 7.7% -22% $23.5M -$6.24M 1.38M -20.9% BlackRock, Inc. Mar 31, 2025
Soleus Capital Master Fund, L.P. 3.7% -45% $12.5M -$9.01M 658K -41.8% Soleus Capital Master Fund, L.P. Jun 30, 2025
MORGAN STANLEY 0.7% $3.3M 116K Morgan Stanley Sep 30, 2025
Invesco Ltd. 0% $110K 6.45K Invesco Ltd. Dec 31, 2024

Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 15M $425M +$32.6M $28.33 164
2025 Q2 13.9M $260M +$336K $18.73 121
2025 Q1 13.9M $250M +$32M $17.99 118
2024 Q4 12.1M $203M +$2.51M $16.82 114
2024 Q3 11.9M $193M +$27.3M $16.18 89
2024 Q2 10.4M $85.3M +$85.1M $8.22 81